Skip to main content
Caplight Logo









CathConnect

CathConnect

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://cathconnect.com/

Last Round

Grant

Oct 9, 2023

Total Funding Raised

$262,000

Company Overview

CathConnect is a medical device company that develops a retrofit attachment for indwelling urinary catheters designed to prevent traumatic accidental removal.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medical deviceFoley cathetercatheter safetyurethral trauma preventionquick-disconnectbreakaway mechanismindwelling cathetermedical hardwarecatheter accessorycatheter dislodgementmedtechclinical devicehospital equipmentpatient safety deviceurology device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CathConnect Comparables

Compare CathConnect with similar companies based on industry and business-model similarity.

CathConnect comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InnoCare Urologics, LLC
85%
Linear Health
80%
Linear Health Sciences
77%

CathConnect Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 9, 2023
AngelSep 1, 2023
GrantJul 1, 2023
GrantJun 1, 2023
AngelMay 17, 2023
Accelerator
Jan 1, 2023

Key People

Founding team and executive leadership

Manny Pacheco

Chief Technology Officer, Co-Founder

Founding Team

Joelle Tudor

Co-Founder and CEO

Founding Team

CathConnect Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2023

    $25K grant received from Life Science Washington Institute and Washington State Department of Commerce.

  • Jun 1, 2023

    Received grant funding from the National Science Foundation.

CathConnect Filings

Explore SEC and related filing metadata, where available.

CathConnect filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CathConnect's valuation, stock price, and market status.

Is CathConnect a public or private company?

CathConnect is a private company.

What is the current stock price of CathConnect?

CathConnect is a private company with no public stock price. No recent secondary market data is available.

How much is CathConnect worth (valuation)?

Valuation information for CathConnect is not publicly available.

Can I buy CathConnect stock?

CathConnect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CathConnect's last funding round?

CathConnect's most recent funding round was Grant on October 9, 2023.

Who are the main investors in CathConnect?

Key investors in CathConnect include Seattle Angel Conference, Buerk Accelerator Program, FBomb Angels, Washington State Department of Commerce, National Science Foundation.

Will CathConnect IPO soon?

No public IPO plans have been announced for CathConnect.

How can I track CathConnect secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CathConnect's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range5
Year Founded2022
Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?